CONSENSUS INTERFERON ± RIBAVIRIN RETREATMENT FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN PEGYLATED INTERFERON/RIBAVIRIN NONRESPONDERS/RELAPSERS: OUTCOMES FROM A NATIONAL CLINICAL PRACTICE SETTING

被引：0
|
作者：
Yee, Helen S. [1 ,2 ]
Cozen, Myrna [1 ,2 ]
Shen, Hui [1 ,2 ]
Chapman, Summer [3 ]
Tortorice, Kathy [3 ]
Cunningham, Fran [3 ]
Wright, Teresa L. [1 ,4 ]
Currie, Sue [5 ]
Monto, Alexander [1 ,2 ]
机构：
[1] Dept Vet Affairs Med Ctr, San Francisco, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Pharm Benefits Management Strateg Healthcare Grp, Hines, IL USA
[4] Roche Mol Diagnost, Pleasanton, CA USA
[5] Clin Care Opt, Reston, VA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
851
引用
收藏
页码：704A / 704A
页数：1
相关论文
共 50 条
  • [1] Hepatitis C virus (HCV) treatment outcomes with consensus interferon with or without ribavirin in peginterferon/ribavirin nonresponders/relapsers: Results from national clinical practice settings
    Yee, Helen S.
    Tortorice, Kathy
    Chopman, Summer
    Cunningham, Fran
    Currie, Sue
    HEPATOLOGY, 2007, 46 (04) : 397A - 398A
  • [2] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [3] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Yee, Helen S.
    Currie, Sue L.
    Tortorice, Kathryn
    Cozen, Myrna
    Shen, Hui
    Chapman, Summer
    Cunningham, Fran
    Monto, Alexander
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2439 - 2448
  • [4] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Helen S. Yee
    Sue L. Currie
    Kathryn Tortorice
    Myrna Cozen
    Hui Shen
    Summer Chapman
    Fran Cunningham
    Alexander Monto
    Digestive Diseases and Sciences, 2011, 56 : 2439 - 2448
  • [5] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [6] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
  • [7] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [8] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [9] Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
    Cho, Hyun Chin
    Gwak, Geum-Youn
    Paik, Yong Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    GUT AND LIVER, 2013, 7 (05) : 585 - 593
  • [10] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
12345